NCT00213252View on ClinicalTrials.gov

Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Asthma, Bronchial
Interventions
DRUG

Montelukast plus prednisolone

Single dose of oral prednisolone with a subsequent daily five-day course of oral Montelukast

DRUG

Prednisolone

Six daily doses of oral prednisolone

Trial Locations (1)

M5G 1X8

The Hospital for Sick Children, Toronto

All Listed Sponsors
collaborator

Merck Frosst Canada Ltd.

INDUSTRY

lead

The Hospital for Sick Children

OTHER

NCT00213252 - Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma | Biotech Hunter | Biotech Hunter